Shared on06 Aug 25Fair value Increased 15%
Driven by a significant improvement in net profit margin despite a higher discount rate, STAAR Surgical's consensus price target has increased from $19.20 to $22.11. What's in the News Alcon Inc.
Shared on23 Apr 25Fair value Decreased 0.86%
AnalystConsensusTarget has increased revenue growth from 1.1% to 1.8%.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 11%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Decreased 3.98%
AnalystConsensusTarget has decreased revenue growth from 14.4% to 1.5%, increased profit margin from 9.5% to 13.0% and decreased future PE multiple from 56.9x to 26.1x.